MORE PENETRATION, GREATER EFFICIENCY
Our vocation for innovation and wish to treat the skin’s conditions stems from our passion to solve health problems.
That is why we began applying the NANOTECH technology in 2008 to develop solutions adapted to every skin need. NANOTECH technology is the knowledge and control of matter at the smallest scale to obtain “nano” sized structures. At Sesderma we are leaders in applying this technology in the development of products and their manufacturing.
During the formulation process, the actives are encapsulated in liposomes with a structure similar to the skin’s. Through them, we manage to reach high levels of penetration and efficacy in the skin.
OUR DIFFERENTIAL VALUE VS CONVENTIONAL COSMETICS
*Study of the penetration of liposomes in the skin and hair (2013). Research Foundation, University Hospital General Valencia.
Commited to innovation
Our labs are at the forefront of the latest innovations in the field. From the onset, the investment in R+D+i was one of the most important assets in the company.
We work in partnership with scientific institutes, technology centres and the best universities. Together, we develop research and innovative solutions for the skin:
We develop collaborative research projects together with:
Research and development of new functionalized liposomes for the treatment of vitiligo and psoriasis
Project description: Vitiligo and psoriasis are chronic skin diseases with a prevalence of 2% and 3% worldwide, respectively. In addition, in some cases patients present an anatomical coexistence of both types of dermatological lesions. Although different studies show that the incidence of psoriasis in patients with vitiligo is not higher than in the general population, this association is not considered rare, but rather underreported in clinics.
Currently, due to the lack of knowledge and the autoimmune nature of these diseases, existing treatments do not represent sustainable solutions due to the high risk of side effects and the lack of specificity at the cellular level..
That is why Dermopartners has proposed to establish a decisive milestone in the sector, through the research and subsequent development of novel functionalized liposomes to respond to the existing limitations in the treatments of vitiligo and psoriasis
Objective: The development of novel systems for transporting functionalized actives that ensure their effectiveness, as well as a high specificity towards the therapeutic targets responsible for the dermatological disorders caused by vitiligo and psoriasis, thereby improving current state of the art results of treatments.
Results: Milestone 1 of the project has been reached and the technology is developed on a laboratory scale